These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1553491)

  • 21. [Amphetamine-induced psychosis or schizophrenia?].
    Rognli EB; Medhus SE; Bramness JG
    Tidsskr Nor Laegeforen; 2015 Feb; 135(3):249-51. PubMed ID: 25668544
    [No Abstract]   [Full Text] [Related]  

  • 22. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The concept of supersensitivity psychosis.
    Kirkpatrick B; Alphs L; Buchanan RW
    J Nerv Ment Dis; 1992 Apr; 180(4):265-70. PubMed ID: 1348269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precipitating factors in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ishiguro T; Goto K; Ikemoto S
    Psychopharmacology (Berl); 1997 Dec; 134(3):303-8. PubMed ID: 9438680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced psychosis associated with crystalline methamphetamine.
    Dore G; Sweeting M
    Australas Psychiatry; 2006 Mar; 14(1):86-9. PubMed ID: 16630206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous amphetamine intoxication: an animal model of the acute psychotic episode.
    Ellison GD; Eison MS
    Psychol Med; 1983 Nov; 13(4):751-61. PubMed ID: 6320247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine neurotransmitter function and spontaneous recurrence of methamphetamine psychosis.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Ann N Y Acad Sci; 1996 Oct; 801():415-29. PubMed ID: 8959056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study on methamphetamine psychosis in a psychiatric clinic--comparison of acute and chronic-type cases].
    Teraoka A
    Seishin Shinkeigaku Zasshi; 1998; 100(7):425-68. PubMed ID: 9778996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An exploratory analysis of neurocognition in methamphetamine-induced psychotic disorder and paranoid schizophrenia.
    Jacobs E; Fujii D; Schiffman J; Bello I
    Cogn Behav Neurol; 2008 Jun; 21(2):98-103. PubMed ID: 18541986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
    Alexander PD; Gicas KM; Willi TS; Kim CN; Boyeva V; Procyshyn RM; Smith GN; Thornton AE; Panenka WJ; Jones AA; Vila-Rodriguez F; Lang DJ; William MacEwan G; Honer WG; Barr AM
    Psychopharmacology (Berl); 2017 May; 234(9-10):1535-1547. PubMed ID: 28190084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
    Srisurapanont M; Arunpongpaisal S; Wada K; Marsden J; Ali R; Kongsakon R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):959-64. PubMed ID: 21277930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options.
    Chiang M; Lombardi D; Du J; Makrum U; Sitthichai R; Harrington A; Shukair N; Zhao M; Fan X
    Hum Psychopharmacol; 2019 Sep; 34(5):e2710. PubMed ID: 31441135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine psychosis: epidemiology and management.
    Glasner-Edwards S; Mooney LJ
    CNS Drugs; 2014 Dec; 28(12):1115-26. PubMed ID: 25373627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration.
    Matsumoto T; Kamijo A; Miyakawa T; Endo K; Yabana T; Kishimoto H; Okudaira K; Iseki E; Sakai T; Kosaka K
    Addiction; 2002 Jul; 97(7):809-17. PubMed ID: 12133119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The clinical course of chronic methamphetamine psychoses].
    Fujimori H; Nakatani Y; Sakaguchi M
    Fortschr Neurol Psychiatr; 1989 Sep; 57(9):383-94. PubMed ID: 2793033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change.
    Yui K; Ishiguro T; Goto K; Ikemoto S; Kamata Y
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(2):103-11. PubMed ID: 10369157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cannabis and Schizophrenia: new findings in an old debate].
    Kawohl W; Rössler W
    Neuropsychiatr; 2008; 22(4):223-9. PubMed ID: 19080993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.